Vaccines
Featured Topics in Life Sciences: Medical Technology | Nanomedicine | Technology | Laboratory Equipment | Biology | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
May 24 | News
The
highly pathogenic hantavirus causes a condition known as hantavirus
pulmonary syndrome (HPS), which has a case fatality rate of 35-40%. To
help the fight against a disease that has no vaccine, U.S. Army
scientists and industry collaborators have successfully protected
laboratory animals from lethal hantavirus disease using a novel approach
that combines DNA vaccines and duck eggs.
Apr 23 | News
While
microemulsions are now used for drug delivery, such as antibiotics and
syrups, using them for vaccines is new area of research. A U.S. Army
major has developed a microemulsion made from five ingredients that
could be a stable, promising candidate delivering a variety of antigens
against diseases such as influenza.
Feb 27 | News
Flu
bugs are common in humans, birds and pigs and have even been seen in
dogs, horses, seals and whales, among others. But for the first time,
scientists have found evidence of flu in bats, reporting a
never-before-seen virus whose risk to humans is unclear.
Feb 7 | News
Biologists
have found new evidence of why mice, people and other vertebrate
animals carry thousands of varieties of genes to make immune-system
proteins named MHCs—even though some of those genes make vertebrate
animals susceptible to infections and to autoimmune diseases.
Jan 23 | News
After
two laboratories reported created new, easier-to-spread version of the
deadly bird flu viruses, research was temporarily halted on Jan. 20. The
pause comes as fierce debate intensifies over how to handle this
high-risk research.
10/21/2011 | News
At
the end of October, the United Nations Environment Programme, or UNEP,
will conduct the third of five meetings to hammer out a treaty that may
involve the comprehensive ban on mercury. The problem, says many health
experts, is that a proposed ban might include thiomersal, a mercury
compound used to prevent contamination and extend the shelf life of
vaccines.
10/17/2011 | News
A team of researchers at the Massachusetts Institute of Technology has developed a new technology that can measure multiple aspects of individual T cells' responses to HIV-infected cells, including their ability to kill them. The technology could make it easier to monitor and design vaccines against HIV.
10/10/2011 | News
Lawrence Livermore National Laboratory,
working with Loyola
University, has won a
$3.5 million grant from the National Institutes of Health to help
develop a new
anthrax vaccine. The grant is the first major NIH-funded biodefense
grant
focused on LLNL's nanolipoprotein technology.
8/8/2011 | News
Unlike
many vaccines, the shot for influenza needs yearly updating. Howard
Hughes Medical Institute scientists have discovered a human antibody
that recognizes many different flu strains and could be the basis for a
longer-lasting vaccine.
7/25/2011 | News
LEUKOCARE AG, a
privately-owned specialist company for protein stabilization and
biological surface coating, announced the
signing of a cooperation agreement with Sanofi Pasteur, the vaccines
division
of Sanofi. As part of this
cooperation, Sanofi Pasteur will explore LEUKOCARE’s SPS platform
technology to
enhance the shelf-life of selected vaccine formulations.
